This is of particular relevance since the utilization of neoadjuvant therapy increased over the study period (from 9.9% to 24.0% [data not shown]) concomitant with a decreasing trend of operative intervention over the same period.
← all excerpts
Factors Associated with Treatment and Survival of Early Stage Pancreatic Cancer in the Era of Modern Chemotherapy: An Analysis of the National Cancer Database.
1
—
—